1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Oncology Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy 1.2.3 Targeted Therapy 1.2.4 Immunotherapy (Biologic Therapy) 1.2.5 Hormonal Therapy 1.2.6 Others 1.3 Market by Application 1.3.1 Global Oncology Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Blood Cancer 1.3.3 Breast Cancer 1.3.4 Gastrointestinal Cancer 1.3.5 Prostate Cancer 1.3.6 Respiratory or Lung Cancer 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Oncology Drugs Market Perspective (2016-2027) 2.2 Oncology Drugs Growth Trends by Regions 2.2.1 Oncology Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Oncology Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Oncology Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Oncology Drugs Industry Dynamic 2.3.1 Oncology Drugs Market Trends 2.3.2 Oncology Drugs Market Drivers 2.3.3 Oncology Drugs Market Challenges 2.3.4 Oncology Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Oncology Drugs Players by Revenue 3.1.1 Global Top Oncology Drugs Players by Revenue (2016-2021) 3.1.2 Global Oncology Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Oncology Drugs Revenue 3.4 Global Oncology Drugs Market Concentration Ratio 3.4.1 Global Oncology Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2020 3.5 Oncology Drugs Key Players Head office and Area Served 3.6 Key Players Oncology Drugs Product Solution and Service 3.7 Date of Enter into Oncology Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Drugs Breakdown Data by Type 4.1 Global Oncology Drugs Historic Market Size by Type (2016-2021) 4.2 Global Oncology Drugs Forecasted Market Size by Type (2022-2027) 5 Oncology Drugs Breakdown Data by Application 5.1 Global Oncology Drugs Historic Market Size by Application (2016-2021) 5.2 Global Oncology Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Oncology Drugs Market Size (2016-2027) 6.2 North America Oncology Drugs Market Size by Type 6.2.1 North America Oncology Drugs Market Size by Type (2016-2021) 6.2.2 North America Oncology Drugs Market Size by Type (2022-2027) 6.2.3 North America Oncology Drugs Market Size by Type (2016-2027) 6.3 North America Oncology Drugs Market Size by Application 6.3.1 North America Oncology Drugs Market Size by Application (2016-2021) 6.3.2 North America Oncology Drugs Market Size by Application (2022-2027) 6.3.3 North America Oncology Drugs Market Size by Application (2016-2027) 6.4 North America Oncology Drugs Market Size by Country 6.4.1 North America Oncology Drugs Market Size by Country (2016-2021) 6.4.2 North America Oncology Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Oncology Drugs Market Size (2016-2027) 7.2 Europe Oncology Drugs Market Size by Type 7.2.1 Europe Oncology Drugs Market Size by Type (2016-2021) 7.2.2 Europe Oncology Drugs Market Size by Type (2022-2027) 7.2.3 Europe Oncology Drugs Market Size by Type (2016-2027) 7.3 Europe Oncology Drugs Market Size by Application 7.3.1 Europe Oncology Drugs Market Size by Application (2016-2021) 7.3.2 Europe Oncology Drugs Market Size by Application (2022-2027) 7.3.3 Europe Oncology Drugs Market Size by Application (2016-2027) 7.4 Europe Oncology Drugs Market Size by Country 7.4.1 Europe Oncology Drugs Market Size by Country (2016-2021) 7.4.2 Europe Oncology Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Oncology Drugs Market Size (2016-2027) 8.2 Asia-Pacific Oncology Drugs Market Size by Type 8.2.1 Asia-Pacific Oncology Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Oncology Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Oncology Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Oncology Drugs Market Size by Application 8.3.1 Asia-Pacific Oncology Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Oncology Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Oncology Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Oncology Drugs Market Size by Region 8.4.1 Asia-Pacific Oncology Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Oncology Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Oncology Drugs Market Size (2016-2027) 9.2 Latin America Oncology Drugs Market Size by Type 9.2.1 Latin America Oncology Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Oncology Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Oncology Drugs Market Size by Type (2016-2027) 9.3 Latin America Oncology Drugs Market Size by Application 9.3.1 Latin America Oncology Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Oncology Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Oncology Drugs Market Size by Application (2016-2027) 9.4 Latin America Oncology Drugs Market Size by Country 9.4.1 Latin America Oncology Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Oncology Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Oncology Drugs Market Size (2016-2027) 10.2 Middle East & Africa Oncology Drugs Market Size by Type 10.2.1 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Oncology Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Oncology Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Oncology Drugs Market Size by Application 10.3.1 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Oncology Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Oncology Drugs Market Size by Country 10.4.1 Middle East & Africa Oncology Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Oncology Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Roche 11.1.1 Roche Company Details 11.1.2 Roche Business Overview 11.1.3 Roche Oncology Drugs Introduction 11.1.4 Roche Revenue in Oncology Drugs Business (2016-2021) 11.1.5 Roche Recent Development 11.2 Celgene 11.2.1 Celgene Company Details 11.2.2 Celgene Business Overview 11.2.3 Celgene Oncology Drugs Introduction 11.2.4 Celgene Revenue in Oncology Drugs Business (2016-2021) 11.2.5 Celgene Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Oncology Drugs Introduction 11.3.4 Novartis Revenue in Oncology Drugs Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Oncology Drugs Introduction 11.4.4 Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Johnson & Johnson 11.5.1 Johnson & Johnson Company Details 11.5.2 Johnson & Johnson Business Overview 11.5.3 Johnson & Johnson Oncology Drugs Introduction 11.5.4 Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021) 11.5.5 Johnson & Johnson Recent Development 11.6 Merck & Co. 11.6.1 Merck & Co. Company Details 11.6.2 Merck & Co. Business Overview 11.6.3 Merck & Co. Oncology Drugs Introduction 11.6.4 Merck & Co. Revenue in Oncology Drugs Business (2016-2021) 11.6.5 Merck & Co. Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Oncology Drugs Introduction 11.7.4 AstraZeneca Revenue in Oncology Drugs Business (2016-2021) 11.7.5 AstraZeneca Recent Development 11.8 Pfizer 11.8.1 Pfizer Company Details 11.8.2 Pfizer Business Overview 11.8.3 Pfizer Oncology Drugs Introduction 11.8.4 Pfizer Revenue in Oncology Drugs Business (2016-2021) 11.8.5 Pfizer Recent Development 11.9 Amgen 11.9.1 Amgen Company Details 11.9.2 Amgen Business Overview 11.9.3 Amgen Oncology Drugs Introduction 11.9.4 Amgen Revenue in Oncology Drugs Business (2016-2021) 11.9.5 Amgen Recent Development 11.10 Eli Lilly 11.10.1 Eli Lilly Company Details 11.10.2 Eli Lilly Business Overview 11.10.3 Eli Lilly Oncology Drugs Introduction 11.10.4 Eli Lilly Revenue in Oncology Drugs Business (2016-2021) 11.10.5 Eli Lilly Recent Development 11.11 AbbVie 11.11.1 AbbVie Company Details 11.11.2 AbbVie Business Overview 11.11.3 AbbVie Oncology Drugs Introduction 11.11.4 AbbVie Revenue in Oncology Drugs Business (2016-2021) 11.11.5 AbbVie Recent Development 11.12 Takeda 11.12.1 Takeda Company Details 11.12.2 Takeda Business Overview 11.12.3 Takeda Oncology Drugs Introduction 11.12.4 Takeda Revenue in Oncology Drugs Business (2016-2021) 11.12.5 Takeda Recent Development 11.13 Astellas 11.13.1 Astellas Company Details 11.13.2 Astellas Business Overview 11.13.3 Astellas Oncology Drugs Introduction 11.13.4 Astellas Revenue in Oncology Drugs Business (2016-2021) 11.13.5 Astellas Recent Development 11.14 Ipsen 11.14.1 Ipsen Company Details 11.14.2 Ipsen Business Overview 11.14.3 Ipsen Oncology Drugs Introduction 11.14.4 Ipsen Revenue in Oncology Drugs Business (2016-2021) 11.14.5 Ipsen Recent Development 11.15 Sanofi 11.15.1 Sanofi Company Details 11.15.2 Sanofi Business Overview 11.15.3 Sanofi Oncology Drugs Introduction 11.15.4 Sanofi Revenue in Oncology Drugs Business (2016-2021) 11.15.5 Sanofi Recent Development 11.16 Bayer 11.16.1 Bayer Company Details 11.16.2 Bayer Business Overview 11.16.3 Bayer Oncology Drugs Introduction 11.16.4 Bayer Revenue in Oncology Drugs Business (2016-2021) 11.16.5 Bayer Recent Development 11.17 Biogen Idec 11.17.1 Biogen Idec Company Details 11.17.2 Biogen Idec Business Overview 11.17.3 Biogen Idec Oncology Drugs Introduction 11.17.4 Biogen Idec Revenue in Oncology Drugs Business (2016-2021) 11.17.5 Biogen Idec Recent Development 11.18 Teva 11.18.1 Teva Company Details 11.18.2 Teva Business Overview 11.18.3 Teva Oncology Drugs Introduction 11.18.4 Teva Revenue in Oncology Drugs Business (2016-2021) 11.18.5 Teva Recent Development 11.18 Otsuka .1 Otsuka Company Details .2 Otsuka Business Overview .3 Otsuka Oncology Drugs Introduction .4 Otsuka Revenue in Oncology Drugs Business (2016-2021) .5 Otsuka Recent Development 11.20 Eisai 11.20.1 Eisai Company Details 11.20.2 Eisai Business Overview 11.20.3 Eisai Oncology Drugs Introduction 11.20.4 Eisai Revenue in Oncology Drugs Business (2016-2021) 11.20.5 Eisai Recent Development 11.21 Merck KGaA 11.21.1 Merck KGaA Company Details 11.21.2 Merck KGaA Business Overview 11.21.3 Merck KGaA Oncology Drugs Introduction 11.21.4 Merck KGaA Revenue in Oncology Drugs Business (2016-2021) 11.21.5 Merck KGaA Recent Development 11.22 Gilead Sciences 11.22.1 Gilead Sciences Company Details 11.22.2 Gilead Sciences Business Overview 11.22.3 Gilead Sciences Oncology Drugs Introduction 11.22.4 Gilead Sciences Revenue in Oncology Drugs Business (2016-2021) 11.22.5 Gilead Sciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Oncology Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Table 3. Key Players of Targeted Therapy Table 4. Key Players of Immunotherapy (Biologic Therapy) Table 5. Key Players of Hormonal Therapy Table 6. Key Players of Others Table 7. Global Oncology Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Oncology Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Oncology Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Oncology Drugs Market Share by Regions (2016-2021) Table 11. Global Oncology Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Oncology Drugs Market Share by Regions (2022-2027) Table 13. Oncology Drugs Market Trends Table 14. Oncology Drugs Market Drivers Table 15. Oncology Drugs Market Challenges Table 16. Oncology Drugs Market Restraints Table 17. Global Oncology Drugs Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Oncology Drugs Market Share by Players (2016-2021) Table 19. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020) Table 20. Ranking of Global Top Oncology Drugs Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Oncology Drugs Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Oncology Drugs Product Solution and Service Table 24. Date of Enter into Oncology Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 27. Global Oncology Drugs Revenue Market Share by Type (2016-2021) Table 28. Global Oncology Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Oncology Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Oncology Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Oncology Drugs Revenue Market Share by Application (2016-2021) Table 32. Global Oncology Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Oncology Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 35. North America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Oncology Drugs Market Size by Application (2016-2021) (US$ Million) Table 37. North America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Oncology Drugs Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Oncology Drugs Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Oncology Drugs Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Oncology Drugs Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Oncology Drugs Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Oncology Drugs Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Oncology Drugs Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Oncology Drugs Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Oncology Drugs Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Oncology Drugs Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Oncology Drugs Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Oncology Drugs Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Oncology Drugs Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Oncology Drugs Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Oncology Drugs Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Oncology Drugs Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Oncology Drugs Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Oncology Drugs Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Oncology Drugs Market Size by Country (2022-2027) & (US$ Million) Table 64. Roche Company Details Table 65. Roche Business Overview Table 66. Roche Oncology Drugs Product Table 67. Roche Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 68. Roche Recent Development Table 69. Celgene Company Details Table 70. Celgene Business Overview Table 71. Celgene Oncology Drugs Product Table 72. Celgene Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 73. Celgene Recent Development Table 74. Novartis Company Details Table 75. Novartis Business Overview Table 76. Novartis Oncology Drugs Product Table 77. Novartis Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 78. Novartis Recent Development Table 79. Bristol-Myers Squibb Company Details Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb Oncology Drugs Product Table 82. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 83. Bristol-Myers Squibb Recent Development Table 84. Johnson & Johnson Company Details Table 85. Johnson & Johnson Business Overview Table 86. Johnson & Johnson Oncology Drugs Product Table 87. Johnson & Johnson Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 88. Johnson & Johnson Recent Development Table 89. Merck & Co. Company Details Table 90. Merck & Co. Business Overview Table 91. Merck & Co. Oncology Drugs Product Table 92. Merck & Co. Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 93. Merck & Co. Recent Development Table 94. AstraZeneca Company Details Table 95. AstraZeneca Business Overview Table 96. AstraZeneca Oncology Drugs Product Table 97. AstraZeneca Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 98. AstraZeneca Recent Development Table 99. Pfizer Company Details Table 100. Pfizer Business Overview Table 101. Pfizer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 102. Pfizer Recent Development Table 103. Amgen Company Details Table 104. Amgen Business Overview Table 105. Amgen Oncology Drugs Product Table 106. Amgen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 107. Amgen Recent Development Table 108. Eli Lilly Company Details Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Oncology Drugs Product Table 111. Eli Lilly Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 112. Eli Lilly Recent Development Table 113. AbbVie Company Details Table 114. AbbVie Business Overview Table 115. AbbVie Oncology Drugs Product Table 116. AbbVie Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 117. AbbVie Recent Development Table 118. Takeda Company Details Table 119. Takeda Business Overview Table 120. Takeda Oncology Drugs Product Table 121. Takeda Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 122. Takeda Recent Development Table 123. Astellas Company Details Table 124. Astellas Business Overview Table 125. Astellas Oncology Drugs Product Table 126. Astellas Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 127. Astellas Recent Development Table 128. Ipsen Company Details Table 129. Ipsen Business Overview Table 130. Ipsen Oncology Drugs Product Table 131. Ipsen Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 132. Ipsen Recent Development Table 133. Sanofi Company Details Table 134. Sanofi Business Overview Table 135. Sanofi Oncology Drugs Product Table 136. Sanofi Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 137. Sanofi Recent Development Table 138. Bayer Company Details Table 139. Bayer Business Overview Table 140. Bayer Oncology Drugs Product Table 141. Bayer Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 142. Bayer Recent Development Table 143. Biogen Idec Company Details Table 144. Biogen Idec Business Overview Table 145. Biogen Idec Oncology Drugs Product Table 146. Biogen Idec Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 147. Biogen Idec Recent Development Table 148. Teva Company Details Table 149. Teva Business Overview Table 150. Teva Oncology Drugs Product Table 151. Teva Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 152. Teva Recent Development Table 153. Otsuka Company Details Table 154. Otsuka Business Overview Table 155. Otsuka Oncology Drugs Product Table 156. Otsuka Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 157. Otsuka Recent Development Table 158. Eisai Company Details Table 159. Eisai Business Overview Table 160. Eisai Oncology Drugs Product Table 161. Eisai Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 162. Eisai Recent Development Table 163. Merck KGaA Company Details Table 164. Merck KGaA Business Overview Table 165. Merck KGaA Oncology Drugs Product Table 166. Merck KGaA Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 167. Merck KGaA Recent Development Table 168. Gilead Sciences Company Details Table 169. Gilead Sciences Business Overview Table 170. Gilead Sciences Oncology Drugs Product Table 171. Gilead Sciences Revenue in Oncology Drugs Business (2016-2021) & (US$ Million) Table 172. Gilead Sciences Recent Development Table 173. Research Programs/Design for This Report Table 174. Key Data Information from Secondary Sources Table 175. Key Data Information from Primary Sources List of Figures Figure 1. Global Oncology Drugs Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Features Figure 3. Targeted Therapy Features Figure 4. Immunotherapy (Biologic Therapy) Features Figure 5. Hormonal Therapy Features Figure 6. Others Features Figure 7. Global Oncology Drugs Market Share by Application: 2020 VS 2027 Figure 8. Blood Cancer Case Studies Figure 9. Breast Cancer Case Studies Figure 10. Gastrointestinal Cancer Case Studies Figure 11. Prostate Cancer Case Studies Figure 12. Respiratory or Lung Cancer Case Studies Figure 13. Others Case Studies Figure 14. Oncology Drugs Report Years Considered Figure 15. Global Oncology Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 16. Global Oncology Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 17. Global Oncology Drugs Market Share by Regions: 2020 VS 2027 Figure 18. Global Oncology Drugs Market Share by Regions (2022-2027) Figure 19. Global Oncology Drugs Market Share by Players in 2020 Figure 20. Global Top Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2020 Figure 21. The Top 10 and 5 Players Market Share by Oncology Drugs Revenue in 2020 Figure 22. Global Oncology Drugs Revenue Market Share by Type (2016-2021) Figure 23. Global Oncology Drugs Revenue Market Share by Type (2022-2027) Figure 24. North America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. North America Oncology Drugs Market Share by Type (2016-2027) Figure 26. North America Oncology Drugs Market Share by Application (2016-2027) Figure 27. North America Oncology Drugs Market Share by Country (2016-2027) Figure 28. United States Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Canada Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Europe Oncology Drugs Market Share by Type (2016-2027) Figure 32. Europe Oncology Drugs Market Share by Application (2016-2027) Figure 33. Europe Oncology Drugs Market Share by Country (2016-2027) Figure 34. Germany Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. France Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. U.K. Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Italy Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Russia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Nordic Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Asia-Pacific Oncology Drugs Market Share by Type (2016-2027) Figure 42. Asia-Pacific Oncology Drugs Market Share by Application (2016-2027) Figure 43. Asia-Pacific Oncology Drugs Market Share by Region (2016-2027) Figure 44. China Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Japan Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. South Korea Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Southeast Asia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. India Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Australia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Latin America Oncology Drugs Market Share by Type (2016-2027) Figure 52. Latin America Oncology Drugs Market Share by Application (2016-2027) Figure 53. Latin America Oncology Drugs Market Share by Country (2016-2027) Figure 54. Mexico Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Brazil Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Middle East & Africa Oncology Drugs Market Share by Type (2016-2027) Figure 58. Middle East & Africa Oncology Drugs Market Share by Application (2016-2027) Figure 59. Middle East & Africa Oncology Drugs Market Share by Country (2016-2027) Figure 60. Turkey Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Saudi Arabia Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. UAE Oncology Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 63. Roche Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 64. Celgene Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 65. Novartis Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 66. Bristol-Myers Squibb Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 67. Johnson & Johnson Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 68. Merck & Co. Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 69. AstraZeneca Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 71. Amgen Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 72. Eli Lilly Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 73. AbbVie Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 74. Takeda Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 75. Astellas Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 76. Ipsen Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 77. Sanofi Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 78. Bayer Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 79. Biogen Idec Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 80. Teva Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 81. Otsuka Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 82. Eisai Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 83. Merck KGaA Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 84. Gilead Sciences Revenue Growth Rate in Oncology Drugs Business (2016-2021) Figure 85. Bottom-up and Top-down Approaches for This Report Figure 86. Data Triangulation Figure 87. Key Executives Interviewed

Roche Celgene Novartis Bristol-Myers Squibb Johnson & Johnson Merck & Co. AstraZeneca Pfizer Amgen Eli Lilly AbbVie Takeda Astellas Ipsen Sanofi Bayer Biogen Idec Teva Otsuka Eisai Merck KGaA Gilead Sciences